期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

根治性放疗对于早期前列腺癌治疗更具优势 被引量：2

下载PDF
导出
摘要 前列腺癌是最常见的男性恶性肿瘤之一，在美国每年约有20多万的新诊断患者，并有3万人死于该疾病[1]。目前，前列腺癌的治疗方法仍以外科手术、内分泌治疗和放射治疗为主。由于该疾病好发于老年人，患者常常由于患有其他慢性疾病或体质衰退等原因无法接受前列腺根治性手术切除治疗。
作者 张晓智 郭嘉
机构地区 西安交通大学医学院第一附属医院肿瘤放疗科
出处 《现代泌尿外科杂志》 CAS 2013年第4期390-391,共2页 Journal of Modern Urology
关键词 前列腺癌 根治性放疗 前列腺癌根治术
分类号 R737.25 [医药卫生—肿瘤]
  • 相关文献

参考文献16

  • 1SIEGEL R,WARD E,BRAWLEY O,et al.Cancer statistics,2011:the impact of eliminating socioeconomic and racial disparities on premature cancer deaths[J].Cancer J Clinic,2011,61(4):212-236.
  • 2董培,刘卓炜,李永红,尧凯,韩辉,秦自科,周芳坚.广东省前列腺癌诊疗情况与预后分析[J].中华临床医师杂志（电子版）,2012,6(15):244-248. 被引量：1
  • 3VOULGARIS S,NOBES JP,LAING RW,et al,State of the art:prostate LDR brachytherapy[J].Prost Canc Prostatic Dis,2008,11(3):237-240.
  • 4SHARKEY J,CANTOR A,SOLC Z,et al.Brachytherapy versus radical prostatectomy in patients with clinically localized prostate cancer[J].Curr Urol Reports,2002.3(3):250-257.
  • 5BLOCK T,CZEMPIEL H,ZIMMENMANN F,et al.Transperineal permanent seed implantation of "lowrisk" prostate cancer:5 year experiences in 118 patients[J].Strahlenger Onkol,2006.182(11):666-671.
  • 6PEIFFERT D.Brachytherapy for localised prostate cancer[J].Cancer Radiother,2007,11:373-378.
  • 7AIZER AA,YU JB,COLBERG JW,et al.Radical prostatectomy vs.intensity modulated radiation therapy in the management of localized prostate adenocarcinoma[J].Radioth Oncol,2009,93(2):185-191.
  • 8ERRMANNT R,RABENALT R,STOLZENBURG JU,et al.Oncological and functional results of open,robotassisted and laparoscopic radical prostatectomy:does surgical approach and surgical experience matter[J].Worl J Urol,2007,25(2):149 -160.
  • 9SANDA MG,DUNN RL,MICHALSKI J,et al.Quality of life and satisfaction with outcome among prostate cancer surivors[J].NE J M,2008,358:1250-1261.
  • 10MARK SL,JOHN LG,LORNA K,et al.Quality of life after surgery,external beam irradiation,or brachytherapy for earlystage prostate cancer[J].Cancer,2007,109(11):2239-2247.

二级参考文献34

  • 1顾方六.Epidemiological survey of benign prostatic hyperplasia and prostatic cancer in China[J].Chinese Medical Journal,2000(4):11-14. 被引量：17
  • 2RIES LAG, HARKINS D, KRAPCHOM, et al. SEER cancer statistics review, 1975-2003 [DB/OL]. National cancer institute 2006E2011-01-303. http://seer, cancer, gov/csr/1975-2003.
  • 3JEMAL A, SIEGAEL R, WARD E, et al. Cancer statistics, 2009[J].CA Cancer J Clin, 2009, 59:225-249.
  • 4JEMAL A, SIEGEL R, WARD E, et al. Cancer statistics 2007 [J].CA Cancer J Clin 2007 ; 57 : 43-66.
  • 5FERLAY J, BRAY F, PISANI P, et al. Cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5 [CP/DK]. version 2.0. Lyon, France: IARC Press, 2004', GLOBOCAN 2002.
  • 6VOULGARIS S, NOBES JP, LAING RW, et al. State-of-the- art: prostate LDR brachytherapy[J].Prostate Cancer Prostatic Dis, 2008,11(3) :237-240.
  • 7PEIFFERT D. Brachytherapy for localised prostate cancer[J]. Cancer Radiother, 2007, 11(6-7): 373-378.
  • 8SHARKEY J, CANTOR A, SOLC Z, et al. Brachytherapy versus radical prostatectomy in patients with clinically localized prostate cancer[J]. Curr Urol Rep, 2002, 3(3):250-257.
  • 9BLOCK T, CZEMPIEL H, ZIMMENMANN F. Transperineal permanent seed implant-tation of "low-risk'prostate cancer: 5- year-experiences in 118 patients [J]. Strahlenher Onkol,2006, 182 (11): 666-671.
  • 10ELLER LS,LEV EL, GEJERMAN G, et al. Prospective study of quality of life of patients receiving treatment for prostate cancer[J]. Nurs Res, 2006,55 ($2) : 28-36.

共引文献10

同被引文献25

  • 1Selth LA,Roberts MJ,Chow CWK,et al.Human seminal fluid as a source of prostate cancer specific microRNA biomarkers.Endocr Relat Cancer,2014,21(4):L17-L21.
  • 2Xu B,Wang N,Wang X,et al.MiR-146a suppresses tumor growth and progression by targeting EGFR pathway and in a p-ERK-dependent manner in castration-resistant prostate cancer.Prostate,2012,72(11):1171-1178.
  • 3Zhu C,Li J,Ding Q,et al.miR-152 controls migration and invasive potential by targeting TGFαin prostate cancer cell lines.Prostate,2013,73(10):1082-1089.
  • 4Flores O,Kennedy EM,Skalsky RL,et al.Differential RISC association of endogenous human microRNAs predicts their inhibitory potential.Nucleic Acids Res,2014,42(7):4629-39.
  • 5Curtale G,Citarella F,Carissimi C,et al.An emerging player in the adaptive immune response:microRNA-146a is a modulator of IL-2expression and activation-induced cell death in T lymphocytes.Blood,2010,115(2):265-273.
  • 6Lin SL,Chiang A,Chang D,et al.Loss of mir-146a function in hormone-refractory prostate cancer.RNA,2008,14(3):417-424.
  • 7Woo HH,LászlóCF,Greco S,et al.Regulation of colony stimulating factor-1 expression and ovarian cancer cell behavior in vitro by miR-128 and miR-152.Mol Cancer,2012,11(1):58.
  • 8Wang XY,Wu MH,Liu F,et al.Differential miRNA expression and their target genes between NGX6-positive and negative colon cancer cells.Mol Cell Biochem,2010,345(1-2):283-290.
  • 9Zheng X,Chopp M,Lu Y,et al.MiR-15b and miR-152 reduce glioma cell invasion and angiogenesis via NRP-2 and MMP-3.Cancer Lett,2013,329(2):146-154.
  • 10Tsuruta T,Kozaki K,Uesugi A,et al.miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer.Cancer Res,2011,71(20):6450-6462.

引证文献2

二级引证文献14

现代泌尿外科杂志
2013年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部